Experience with aspiration in cases of amebic liver abscess in an endemic area

Eur J Clin Microbiol Infect Dis. 2005 Jun;24(6):428-30. doi: 10.1007/s10096-005-1338-2.

Abstract

The study presented here was performed to evaluate the need for aspiration in patients with amebic liver abscess (ALA). Patients older than 12 years with a diagnosis of ALA based on clinical features, ultrasound results, and positive amebic serology were included in the study (n=144). Serological testing was performed to detect the presence of immunoglobin G antibody against Entamoeba histolytica, and a value of more than 0.4 optical density units was considered positive. All patients were given intravenous metronidazole (500 mg every 8 h) and their clinical progress and need for abscess aspiration was documented. Fever, pain in the upper abdomen, and tender hepatomegaly was seen in 133 (92.3%), 128 (88.8%), and 144 (100%) patients, respectively. Multiple abscesses were seen in 40 (27.7%) patients. Six (4.1%) patients died. Seventy-one (49.3%) patients responded to metronidazole alone. A total of 73 (50.69%) patients required aspiration of the abscess. This study shows that almost 50% of the patients with amebic liver abscess failed to respond to metronidazole and required aspiration.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antiprotozoal Agents / therapeutic use
  • Female
  • Humans
  • Liver Abscess, Amebic / therapy*
  • Male
  • Metronidazole / therapeutic use
  • Middle Aged
  • Prospective Studies
  • Suction

Substances

  • Antiprotozoal Agents
  • Metronidazole